Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Capital Expenditures: 2017-2025

Historic Capital Expenditures for Arcus Biosciences (RCUS) over the last 8 years, with Mar 2025 value amounting to $1.0 million.

  • Arcus Biosciences' Capital Expenditures fell 75.00% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $7.0 million, marking a year-over-year decrease of 70.83%. This contributed to the annual value of $6.0 million for FY2024, which is 75.00% down from last year.
  • As of Q1 2025, Arcus Biosciences' Capital Expenditures stood at $1.0 million, which was down 0.00% from $1.0 million recorded in Q4 2024.
  • In the past 5 years, Arcus Biosciences' Capital Expenditures ranged from a high of $10.0 million in Q3 2023 and a low of $1.0 million during Q2 2022.
  • Moreover, its 3-year median value for Capital Expenditures was $4.0 million (2024), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Arcus Biosciences' Capital Expenditures soared by 2,272.27% in 2021, and later slumped by 90.00% in 2024.
  • Quarterly analysis of 5 years shows Arcus Biosciences' Capital Expenditures stood at $8.4 million in 2021, then crashed by 74.55% to $2.0 million in 2022, then spiked by 400.00% to $6.0 million in 2023, then plummeted by 83.33% to $1.0 million in 2024, then crashed by 75.00% to $1.0 million in 2025.
  • Its Capital Expenditures was $1.0 million in Q1 2025, compared to $1.0 million in Q4 2024 and $1.0 million in Q3 2024.